Patrick F. Williams Staar Surgical CO (STAA) insider trading activity

Patrick F. Williams is Chief Financial Officer of STAAR SURGICAL CO. Currently has a direct ownership of 45,475 shares of STAA, which is worth approximately $1.1 Million. The most recent transaction as insider was on Mar 07, 2024, when has been sold 2,614 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.5K

0% 3M change

6.1% 12M change

Total Value Held $1.1 Million

Patrick F. Williams Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2024	BUY Exercise of conversion of derivative security	-	2,614 Added 5.44%	45,475 Common Stock
Aug 10 2023	SELL Payment of exercise price or tax liability	$111,969 $44.1 p/Share	2,539 Reduced 5.59%	42,861 Common Stock
Aug 10 2023	BUY Exercise of conversion of derivative security	-	5,122 Added 10.14%	45,400 Common Stock
Jun 06 2023	SELL Payment of exercise price or tax liability	$108,867 $54.79 p/Share	1,987 Reduced 4.19%	45,400 Common Stock
Jun 06 2023	BUY Exercise of conversion of derivative security	-	5,121 Added 9.75%	47,387 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$16,366 $56.63 p/Share	289 Reduced 0.86%	33,492 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	12,184 Added 21.06%	45,676 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$61,792 $58.13 p/Share	1,063 Reduced 3.05%	33,781 Common Stock
Mar 07 2023	BUY Exercise of conversion of derivative security	$99,460 $58.13 p/Share	1,711 Added 4.6%	35,492 Common Stock
Jun 07 2022	BUY Exercise of conversion of derivative security	-	5,121 Added 12.81%	34,844 Common Stock
Mar 07 2022	BUY Exercise of conversion of derivative security	-	9,225 Added 20.93%	34,844 Common Stock
Sep 16 2021	SELL Open market or private sale	$713,765 $139.38 p/Share	5,121 Reduced 16.66%	25,619 Common Stock
Aug 11 2021	SELL Open market or private sale	$351,450 $140.58 p/Share	2,500 Reduced 7.52%	30,740 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	-	5,121 Added 13.35%	33,240 Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	-	2,513 Added 7.03%	33,240 Common Stock

Also insider at

BRTX

BioRestorative Therapies, Inc. Healthcare

PFW